Can a spe­cial chew­ing gum slick away Covid-19 from sali­va? Penn re­searchers start clin­i­cal tri­al to find out

3 years ago
Discovery
Coronavirus

With pos­i­tive PhII NASH da­ta in tow, Akero opens $175M pub­lic of­fer­ing

3 years ago
Financing

Still leery about an­i­mal deaths, FDA lifts a full hold on Friedre­ich’s atax­ia drug — but there’s a big ...

3 years ago
FDA+

Take­da’s man­u­fac­tur­ing site in Bel­gium gets a €300M boost for plas­ma ther­a­py pro­duc­tion

3 years ago
Financing
Manufacturing

A $105M SPAC deal? Re­al­ly? A biotech with deep Chi­na roots is mak­ing a now-rare flip on­to Nas­daq

3 years ago
Financing

'Not To­day, Flu': Sanofi en­lists Se­in­feld star Ja­son Alexan­der to boost flu vac­ci­na­tions this fall

3 years ago
Pharma
Marketing

Gov­ern­ment-paid ex­perts help­ing in­dus­try at the ta­ble with FDA? Agency spells out guardrails

3 years ago
FDA+

Backed by five phar­ma gi­ants and a crew of Penn su­per­stars, a start­up us­es mR­NA to cre­ate in vi­vo CAR-T — with a ...

3 years ago
Financing
Startups

CSL takes the wraps off a big new R&D cen­ter as it eyes vac­cines, cell and gene ther­a­pies

3 years ago
R&D
Pharma

‘Dif­fi­cult to go pub­lic with’: Spar­ingVi­sion turns to ex­ist­ing back­ers to fund its first two oc­u­lar gene ther­a­py ...

3 years ago
Financing
Startups

Ab­b­Vie un­veils 'See Your­self' Botox cam­paign, days af­ter new ri­val ap­proved

3 years ago
Pharma
Marketing

Ab­b­Vie spon­sors on­line atopic der­mati­tis doc­u­men­tary de­but, re­veals new lifestyle da­ta

3 years ago
Pharma
Marketing

As­traZeneca wins fed­er­al class-ac­tion suit, judge dis­miss­es share­hold­er­s' mis­lead­ing claims

3 years ago
Pharma
Law

New gener­ics save pa­tients bil­lions per year, ac­cord­ing to FDA re­port

3 years ago
Pharma
FDA+

Form 483 un­masks man­u­fac­tur­ing is­sues at Alvotech be­fore its CRL, and one for Au­robindo too

3 years ago
Pharma
FDA+

Mar­ket­ingRx roundup: Am­gen ‘sum­mer of sci­ence’ sun­sets In­sta­gram run; Pfiz­er vaults in­to top 10 of con­sumer loy­al ...

3 years ago
Pharma
Marketing

So­cial me­dia meets sci­ence in ‘Lab Shenani­gans’ with Tik­Tok-fa­mous re­searcher — and some­times Pfiz­er part­ner

3 years ago
Pharma
Marketing

Biotech-backed non­prof­it joins with FDA to stan­dard­ize process for sub­mit­ting in vit­ro phar­ma­col­o­gy da­ta

3 years ago
FDA+

'Re­al­ly in­clude every­one in the tri­al': A Q&A with the pro­to­col chair of the PhI­II mon­key­pox an­tivi­ral study

3 years ago
R&D
Pharma

Ru­bius re­sorts to lay­offs and aban­dons its lead pro­grams as its sur­vival strat­e­gy

3 years ago
People
R&D

Two biotechs go for pub­lic of­fer­ings; Pfiz­er part­ner ex­pands on­col­o­gy col­lab

3 years ago
News Briefing

With fresh $160M, Rayze­Bio plots sprint through the clin­ic for lead ra­dio­phar­ma­ceu­ti­cal pro­gram — build­ing on ...

3 years ago
Financing

Forge Bi­o­log­ics con­tin­ues its hot streak with $90M round to boost gene ther­a­py man­u­fac­tur­ing ser­vices

3 years ago
Financing
Outsourcing

Im­ple­ment­ing 'Right-to-Try': FDA sig­nals like­li­hood of on­ly min­i­mal man­u­fac­tur­er par­tic­i­pa­tion

3 years ago
Pharma
FDA+
First page Previous page 457458459460461462463 Next page Last page
A service from the Financial Times